Research on tradional Chinese medicine in treating the commmom disease-the National Science and Technology Pillar Program in the Eleventh Five-year Plan Period

Western medicine and the tradional Chinese medicine Rx research for IGR with metabolic syndrome

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-09000468

Enrollment

Unknown

Registered

2009-01-18

Start date

2009-02-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic syndrome

Interventions

A:sport and life style intervintion, integrated Chinese Medicine by bianzhen-lunzhi and western medicine

B:sport and life style intervintion and western medicine

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnosis standard of both MS and IGR; 2. Meet the Bianzhen-lunzhi diagnosis standard of traditional Chinese medicine; 3. Age 18-70 years old; 4. SP<180 mmHg, DP<100mmHg; 5. Signed the consensus form.

Exclusion criteria

Exclusion criteria: 1. T1DM or FPG>13mmol/L; 2. With history of myocardial infarction; 3. Allergy to medicine; 4. Pregnant and breast-feeding woman; 5. Psychopathy and complier discordance.

Design outcomes

Primary

Measure	Time frame
HbA1c;blood sugar;blood pressure;Serum total cholesterol concentration;	—

Secondary

Measure	Time frame
Signs of Traditional Chinese Medicine;size of waist line;body weight;	—

Countries

China

Contacts

Public ContactShi Yan

shiyan@lnutcm.edu.cn+86 024 31207048

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026